Clinical trial data can offer a treasure trove of insight – but first it needs to be unlocked.
The number of clinical trial data sets available for secondary analysis has been growing steadily over the last year. While encouraging, there is a need to also ensure that this data is properly de-identified.
The webinar Double-Blind will set expectations about what is needed in a de-identification solution for clinical trial data, and offer a pragmatic look at emerging standards in this area.
Key Learning Objectives:
- Review the standards and regulations in place;
- Understand the risks and mitigate them; and,
- Learn what de-identification is and isn’t–then how to apply it to clinical trial data.
Khaled El Emam, CEO
Luk Arbuckle, Director of Analytics